摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氯丙酸丙酯 | 1569-03-5

中文名称
2-氯丙酸丙酯
中文别名
——
英文名称
2-chloro-propionic acid propyl ester
英文别名
2-Chlor-propionsaeure-propylester;n-propyl chloropropionate;propyl-2-chloropropionate;Propyl 2-chloropropanoate
2-氯丙酸丙酯化学式
CAS
1569-03-5
化学式
C6H11ClO2
mdl
MFCD06252278
分子量
150.605
InChiKey
XVDQGLUGZORASO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    68 °C(Press: 23 Torr)
  • 密度:
    1.054±0.06 g/cm3(Predicted)
  • 保留指数:
    923;930;932;941;950;932;932

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    9
  • 可旋转键数:
    4
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.833
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2915900090

SDS

SDS:63501d5029c54a279bb4590244b9c3df
查看

反应信息

  • 作为反应物:
    描述:
    2-氯丙酸丙酯对苯二酚 在 potassium hydroxide 作用下, 以 二甲基亚砜 为溶剂, 生成 (R, S)-propyl 4-(2-hydroxyphenoxy)propanoate
    参考文献:
    名称:
    Resolution of (R, S)-ethyl-2-(4-hydroxyphenoxy) propanoate using lyophilized mycelium of Aspergillus oryzae WZ007
    摘要:
    The mycelium of Aspergillus oryzae WZ007 was successfully developed to kinetic resolution of (R, S)-ethyl-2-(4-hydroxyphenoxy) propanoate ((R, S)-EHPP) for production of (R)-ethyl-2-(4-hydroxyphenoxy) propanoate ((R)-EHPP). The key biocatalytic process parameters (pH, temperature, rotation speed and substrate concentration) were optimized. Under the optimum conditions, the optical purity of (R)-EHPP was improved up to >99% when the conversion was above 49%. A. oryzae WZ007 whole-cell lipase exhibited high reaction capacity, enantioselectivity and good reusability. The tolerable substrate concentration was 0.5 mol/L, and dry mycelium of A. oryzae WZ007 maintains over 80% of its initial activity after eight repeating cycles. Therefore the enzymatic preparation of (R)-EHPP route was suitable for industrial application. (C) 2013 Elsevier B.V. All rights reserved.
    DOI:
    10.1016/j.molcatb.2013.07.016
点击查看最新优质反应信息

文献信息

  • Transition metal compound, polymerization-initiator system comprising the same, and process for producing polymer
    申请人:Uemura Makoto
    公开号:US20070270521A1
    公开(公告)日:2007-11-22
    A transition metal compound represented by the formula, [(CpR 1 m )(CO) 2 M 1 ][M 2 (CO) 2 (CpR 2 n )], wherein Cp is a cyclopentadienyl ring, R 1 and R 2 are independently of each other a hydrocarbyl group having 1 to 20 carbon atoms, and each of at least one R 1 and at least one R 2 is a hydrocarbyl group having 5 to 20 carbon atoms, m and n are independently of each other an integer of 1 to 5, and M 1 and M 2 are independently of each other a transition metal atom of the group 8 in the periodic table of elements; a polymerization-initiator system comprising said transition metal compound; and a process for producing a polymer in the presence of the polymerization-initiator system.
    一个由该公式表示的过渡金属化合物,[(CpR1m)(CO)2M1][M2(CO)2(CpR2n)],其中Cp是一个环戊二烯环,R1和R2是独立的烃基团,含有1至20个碳原子,至少一个R1和至少一个R2是含有5至20个碳原子的烃基团,m和n是独立的1至5的整数,M1和M2是元素周期表中8族的过渡金属原子;包括所述过渡金属化合物的聚合物化引发剂系统;以及在聚合物化引发剂系统存在的情况下生产聚合物的过程。
  • PROCESS FOR PRODUCING WINE LACTONE
    申请人:Yagi Kenji
    公开号:US20130030193A1
    公开(公告)日:2013-01-31
    The present invention relates to a method comprising (A) reacting a β-keto ester with a 2-halo ester under basic conditions to obtain a 2-aceto-3-methyl-succinic acid ester; (B) reacting the resulting 2-aceto-3-methyl-succinic acid ester with methyl vinyl ketone under basic conditions, optionally followed by a decarboxylation reaction and hydrolysis, etc., to obtain an α-methyl-γ-keto acid; and (C) reducing the resulting α-methyl-γ-keto acid to obtain wine lactone or a stereoisomer thereof or a mixture thereof. Alternatively, the present invention relates to a method comprising step (A) as recited above; (B) reacting the resulting 2-aceto-3-methyl-succinic acid ester with methyl vinyl ketone under basic conditions, followed by decarboxylation reaction to obtain an α-methyl-γ-keto acid ester; and (E) reducing the resulting α-methyl-γ-keto acid ester in the presence of a ruthenium complex having a specific structure and in the presence of a hydrogen donor to obtain wine lactone or a stereoisomer thereof or a mixture thereof.
    本发明涉及一种方法,包括:(A)在碱性条件下反应β-酮酯和2-卤代酯,以获得2-乙酰基-3-甲基琥珀酸酯;(B)在碱性条件下反应所得的2-乙酰基-3-甲基琥珀酸酯和甲基乙烯酮,随后可选择进行脱羧反应和水解等步骤,以获得α-甲基-γ-酮酸;(C)在还原剂的作用下还原所得的α-甲基-γ-酮酸,以获得酒内酯或其立体异构体或其混合物。另外,本发明还涉及一种方法,包括步骤(A)如上所述;(B)在碱性条件下反应所得的2-乙酰基-3-甲基琥珀酸酯和甲基乙烯酮,随后进行脱羧反应,以获得α-甲基-γ-酮酸酯;(E)在具有特定结构的铑配合物和氢供体的存在下还原所得的α-甲基-γ-酮酸酯,以获得酒内酯或其立体异构体或其混合物。
  • Organic Bismuth Compound, Method for Producing Same, Living Radical Polymerization Initiator, Method for Producing Polymer Using Same, and Polymer
    申请人:Yamago Shigeru
    公开号:US20070265404A1
    公开(公告)日:2007-11-15
    An organobismuth compound represented by the formula (1) wherein R 1 and R 2 are C 1 -C 8 alkyl, aryl, substituted aryl or an aromatic heterocyclic group, R 3 and R 4 are each a hydrogen atom or C 1 -C 8 alkyl, and R 5 is aryl, substituted aryl, an aromatic heterocyclic group, acyl, amido, oxycarbonyl or cyano.
    一种有机铋化合物,其化学式为(1),其中R1和R2为C1-C8烷基、芳基、取代芳基或芳香族杂环基,R3和R4分别为氢原子或C1-C8烷基,R5为芳基、取代芳基、芳香族杂环基、酰基、酰胺基、氧羰基或氰基。
  • Method for treating osteoporosis
    申请人:Takeda Chemical Industries, Ltd.
    公开号:EP0146921A2
    公开(公告)日:1985-07-03
    A compound of the formula wherein R1 is hydrogen or hydroxy, R2 and R3 are independently hydrogen or lower alkyl and Y is carboxyl or a group convertible to carboxyl is effective for prevention or treatment of osteoporosis.
    式中的化合物 其中 R1 为氢或羟基,R2 和 R3 独立地为氢或低级烷基,Y 为羧基或可转化为羧基的基团,可有效预防或治疗骨质疏松症。
  • Benzopyran-4-on derivatives and their production
    申请人:Takeda Chemical Industries, Ltd.
    公开号:EP0146922A2
    公开(公告)日:1985-07-03
    Novel benzopyran-4-on derivatives of the formula wherein R1 is hydrogen or hydroxy and R2 is lower alkyl and production theirof.
    式中 R1 为氢或羟基,R2 为低级烷基的新型苯并吡喃-4-on 衍生物及其制备方法。 其中 R1 为氢或羟基,R2 为低级烷基及其衍生物。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物